Navigating Healthcare's Ever-Changing Landscape with Consulting Firms

In 2023, the worldwide healthcare consulting services market recorded a revenue of USD 31.7 billion. Forecasts predict a robust compound annual growth rate (CAGR) of 11.4% from 2024 to 2030, ultimately reaching a projected value of USD 66.6 billion by 2030.

This can be credited to the growing rate of healthcare digitalization, brand positioning, aggressive marketing, and acceptance of new techs in medical sciences. Furthermore, the positive changes in the healthcare IT landscape because of the robust backing by the government in emerging nations boost the industry.

The industry for consulting facilities is growing mainly because of the fast acceptance of digitalization. Furthermore, key companies offering healthcare services are focusing on bringing technical improvements for offering precise and competitive data to healthcare providers. 

The digital health consulting category will advance at the fastest rate during the forecast period. This is mainly because of the acceptance of new techs in the medicinal field, mainly digital solutions over paper-based administrative methods in developed nations. 

In 2023, the North American region has experienced the largest share, of approximately 45%, and it is projected to show a strong CAGR during the forecast period. This is mainly because of the ample government funding for the making of nationwide and state-wide healthcare data exchanges, and also the increasing acceptance of healthcare IT solutions. 

Moreover, the high acceptance of digital solutions by public healthcare agencies, biotechnology & pharmaceutical businesses, hospitals, and other related establishments makes the region lucrative for healthcare consulting businesses.

Read More

Skin Replacements and Substitutes Industry Growth and Future Analysis

In 2023, the skin replacements and substitutes market brought in revenue totaling USD 1,178.2 million. With a projected compound annual growth rate (CAGR) of 7.0% from 2024 to 2030, it is anticipated to reach USD 1,869.2 million by 2030. This is mainly because of the increasing expenditure on appearance, growing populace, rising occurrence of burns and skin illnesses, and mounting life expectancy throughout the globe.

The growing burns occurrence is one of the sturdiest propellers in the industry. The WHO says that around 0.18 million individuals die of burns each year, while in India alone, more than 1 million individuals are affected by them.

The count of burn cases is lesser in high-income nations, while it is a key reason for disability-adjusted life years in low- and middle-income nations. Additionally, non-deadly burns are a key cause of illness. The mainstream of the cases is reported in homes and offices, among which most happen accidentally.

On the basis of product, the acellular category is projected to lead the skin replacements industry, with a revenue share of approximately 45% in 2030. An acellular skin replacement can be achieved in any demographic. It is suitable for the pediatric population, and it can be utilized in excised and insincere wounds.

Geographically, in 2023, the North American region will lead the industry, with approximately USD 0.6 billion in revenue, because of the growing expenditure on skincare, rising awareness of the appearance of advancing treatments obtainable, the growing pace of improvements in healthcare tech, and the existence of sophisticated medical facilities.

Read More

APAC Is Dominating Cryogenic Pump Market

In 2021, the cryogenic pump market size stood at USD 1,407.6 million, which is projected to witness a 3.1% CAGR during 2021–2030, reaching USD 1,860.1 million by 2030. 

P&S Intelligence majorly credits this growth to the increasing installation of such pumps in the metallurgy, chemicals, and electronics sector. Along with, the surge in expenditure throughout the energy generation industry armed with the shift toward energy production from renewable and natural gas resources to reduce carbon emission.

The nitrogen category is all set to experience the fastest growth rate of approximately 3%, in the near future. This can be owed to the extensive utilization of nitrogen gas for the maintenance of plants, and start-up and shutdown provisions of refineries and petrochemical companies.

Thus, the increasing utilization of nitrogen gas in numerous industries, including metallurgy, healthcare, and oil and gas, is escalating the acceptance of cryogenic pumps for capturing the gas and its vapor from the base.

The oil and gas sector is the largest utilizer of cryogenic pumps in the industry, owing to the increasing production of natural gas because of its rising demand from the special chemical, petrochemical, fertilizer, and refining industries.

In 2021, APAC cryogenic pump market  was largest revenue generator, with USD 538.2 million, and projected to continue its dominance in the future as well. This can be credited to the rapid urbanization; the growth in industries, including energy & power and metallurgy in Japan, China, and India, and the escalation in the requirement for power across the region. Additionally, in India, the government is preparing to guarantee a 24*7 electricity supply.      

In order to get this target, the country needs to improve its energy generation systems. Therefore, the government is focusing more on natural gas-fired power plants, which, indeed, will grow the demand for cryogenic pumps in the coming few years.

Hence, the increasing installation of such pumps in the metallurgy, chemicals, and electronics sector, the demand for cryogenic pumps will increase in the future.

Read More

Transdermal Drug Delivery Systems Market is Led by the North American Region

The total value of the transdermal drug delivery systems market was USD 4.2 billion in 2023, and it will power at a compound annual growth rate of 4.7% by the end of this decade, to touch USD 5.8 billion in 2030.

The sector is mostly driven by the rising incidence of chronic illnesses, and for the same, a conservative drug delivery system is weaker than required due to hepatic first-pass metabolism.  What is meant by this is that, when utmost oral drugs enter the liver, they are mostly digested before reaching the targeted tissue, therefore bringing about insufficient efficacy.

More than one billion people at a global level smoke cigarette, with incidence continuing to be high in spite of surveillance, educational, and supply restriction efforts on the international and national levels.

This factor is driving the requirement for transdermal nicotine patches for ages.  If the reports are to be believed, as opposed to a placebo administered for a year, nicotine patches are 50–60% more successful in helping individuals give up cigarettes.

North American transdermal drug delivery systems market is the leader. The expansion in this continent is chiefly driven by patent expirations, letting more businesses to enter the industry with generic alternatives of these devices.

Also, the relaunch of previously failed drugs for subcutaneous delivery and the vast spending by the stalwarts on related research and development are key reasons for the substantial share seized by this region.

Due to the growing incidence of chronic illnesses all over the world, the demand for transdermal drug delivery systems is on the rise. This trend will continue in the years to come as well. 

Read More

Auto Injectors Industry was Led by the North American Region

According to the latest market research study published by P&S Intelligence, the auto injectors market made a total revenue of USD 1,011 million in 2023, and it will propel at a rate of 14.8% in the years to come, to touch a value of USD 2640.2 million in 2030.

The key factors powering the industry expansion include the mounting requirement for the drug administration ease, growing incidence of chronic and lifestyle associated diseases, and evolving healthcare technologies.

According to the WHO, over 16 billion injections are given on a yearly basis at a global level. So, the rising need for ease and safety throughout the procedure is powering the advance of the industry.

North America is the leader of auto injectors market, and this prominent position will persist in the years to come as well. This is for the reason that the continent provides ready reimbursement for the use of autoinjectors. Furthermore, the growing occurrence of anaphylactic shock will encourage the acceptance of auto-injectors filled with epinephrine. Moreover, the two nations in the region exhibit a high awareness with regards to self-administration drug delivery devices.

The fastest growth is observed by the APAC region, chiefly as a result of the growing occurrence of diabetes. Since diabetics need normal insulin administration, auto-injectors save the trouble of seeing a medic every time and, therefore, make them independent. 

Moreover, the mounting occurrence of severe reactions as a result of food allergies is driving the requirement for epinephrine injections.

Due to the increasing occurrence of lifestyle and chronic diseases all over the world, the demand for auto injectors is on the rise. This trend wil continue in the near future as well.

Read More

North America Is Dominating Active Implantable Medical Devices Industry

The market size for active implantable medical devices was valued at USD 22.5 billion in 2023 and is projected to grow to USD 37.1 billion by 2030, with a compound annual growth rate of 7.5% from 2024 to 2030.

The occurrence of chronic illnesses is increasing, the population is rapidly aging, cardiovascular and neurological illnesses are becoming more dominant, and the implantable medicinal device tech is advancing. Apart from such reasons, the industry advance is aided by the increasing funding to develop technically advanced items, increasing acceptance of neurostimulators, and growing growth in and awareness regarding medical implants.

The rising aging population is one of the key reasons behind the development of this sector. According to the World Health Organization, 2 in 12 people worldwide will be 60 years old or more by 2030. By this time, the count of individuals who are 60 years and older will touch 1.4 billion from 1 billion in 2020. Furthermore, the number of people who are 80 years or older will triple in 2020–2050 and touch 426 million.

In 2023, the hospital category, based on end users, dominated the market. This can be credited to the huge aged population and the surging occurrence of chronic illness, the requirement for healthcare facilities is increasing. 

Hospitals face an increased influx of patients, leading to greater demand for medical equipment used in patient monitoring, treatment, and diagnosis. Additionally, hospitals often provide specialized procedures and therapies necessitating specific equipment.

In 2023, based on product, the implantable cardioverter defibrillators category was the major contributor to the market. This growth can be credited to the growing count of people with cardiovascular diseases worldwide, the growing requirement for such life-saving apparatus in developing nations, and the arrival of tech technical innovations in such devices.

Read More

Surface Computing Market is Led by North America

The surface computing market was USD 61.2 billion in 2023, and it will rise to USD 505.5 billion, powering at a 35.3% compound annual growth rate, by 2030.

To learn more about this report: https://bit.ly/3NTBNKA

This growth is mainly because of the surging use of natural user interfaces for interacting with users. Additionally, surface computers have multi-touch as well as multiuser technologies, which assist in the identification of various objects physically with the help of touch. 

Moreover, they are employed for different applications, such as revolving, resizing, choosing, and moving, allowing the identification of objects in real-time.

The curved category, on the basis of display type, is likely to advance at a higher rate, of 35.6%, in the years to come. This can be because these devices have developed visual quality, enhanced efficiency, and reduced eye strain.

North America is the largest contributor to the industry, and it will remain the largest, generating USD 33.6 billion, by 2030. This can be mainly because of the increasing disposable salary as well as the existence of major companies.

APAC is likely to advance at the highest rate, of 35.8%, during this decade. This is because of the rising acceptance of innovative and new technologies, the growing need of customers for more immersive experiences in the digital world, and high funding by several tech giants in this region. 

With the increasing acceptance of natural user interfaces for interacting with users, the surface computing industry will continuously advance in the coming years.

Read More

North America was the Leader of the Multiplex Assays Market

The multiplex assays market produced USD 3,918 million revenue in 2023, and it will power at a rate of 9% by the end of this decade, touching USD 7,103.5 million by 2030.

To learn more about this report: https://bit.ly/4aNVHAn

The main factor powering the industry is the growing incidence of chronic ailments and infectious diseases. Also, the growing requirement for effective analytical platforms in research and medical diagnostics, to decrease the costs for researchers, healthcare providers, and patients, is a robust contributor.

On the basis of product, the consumables category led the industry with a share, of 45%, in 2023. It was because of the increase in the count of diagnostic tests and surge in research actions by life sciences companies.

For example, in January 2023, Novo Nordisk, a pharma company, publicized a USD 6-million grant for Durham Technical Community College, for supporting the later’s life sciences program and set up a novel training center with area of 35,000 square feet.

The protein-based category led the multiplex assays market, with a 50%, share in 2023, due to the growing applications of these kinds of products in proteomics studies. Furthermore, protein-based assays are extensively used in research to recognize the protein concentration, electrophoresis, cell biology and other analytes.

The flow cytometry category led the industry in 2023, because of the numerous applications of this tech in the discovery and measurement of proteins and RNA and in the assessment of cell health.

For instance, Life Sciences Core Facilities, the Flow Cytometry Unit, Weizmann Institute of Science’s is making the use of imaging flow analyzers that combine the high-amount quantification of flow cytometry with microscopy and aid in the study of post-translational alterations and protein, protein interactions in different contexts.

North America led the industry with a share of 55%, in 2023, and it will power at a considerable rate, as a result of the increase in the research and development activities by biotech and pharma companies for the expansion of new drugs and diagnostic solutions. 

For example, in Jan 2023, PharmaEssentia Corporation publicized plans for a new PIRC in Greater Boston, Massachusetts. Likewise, in October 2022, Lineage Cell Therapeutics Inc. publicized the opening of a novel research and development facility in California and the development of its GMP-compliant capability in Israel. Lineage’s novel facility in California will extend its R&D competences in the U.S. and support the expansion of present and future allogeneic cell transplant programs.

It is because of the growing prevalence of chronic and infectious diseases all over the world, the demand for multiplex assays is on the rise. This trend will also continue in the years to come as well.

Read More

Growth of Elderly People is Responsible for the Self-Monitoring Blood Glucose Devices Market Expansion

The self-monitoring blood glucose devices market made USD 25.3 billion in 2023, and it will advance at a rate of 9.7% by the end of this decade to touch USD 48.2 billion by 2030.

The industry growth has a lot to do with the growing occurrence of diabetes, increasing populace of elderly people, tech progressions, booming consciousness of diabetes care, increasing count of obese people, and favorable health insurance and repayment scenario.

Self-sugar-measuring gadgets are used in the monitoring of type 1 and 2 diabetes, and a few other ailments. Amongst all applications, type 2 diabetes had the largest share, of more than 50%, in 2023.

Type 2 diabetes is a common lifestyle ailment that can cause key health problems, chiefly in the blood vessels of the eyes, kidneys, and the nerves. Some of the key problems of the ailment are diabetic retinopathy and diabetic nephropathy.

Tech progressions in SMBG gadgets is a key trend in the self-monitoring blood glucose devices market, as the use of new-age devices decreases the time taken to test sugar levels as opposed to the traditional approaches used in labs. Furthermore, most of these devices are moveable and suitable to carry.

The unparalleled aging rate observed in the worldwide populace is a key contributor to the diabetes occurrence, and elderly people represent one of the fastest-growing segments of the diabetic populace. In emerging nations, the increase in the occurrence of chronic non-infectious illnesses, such as diabetes, cancer, and heart ailment, hints at alterations in the lifestyles and diets, along with aging.

Nearly 80% of the world’s older people will be living in emerging regions by 2050. Also, the number of people aged 60 years or more in emerging regions will surge to 1.7 billion by 2050.

It is because of the increasing prevalence of diabetes all over the world, the requirement for self-monitoring blood glucose devices is on the rise3. This will continue in the years to come as well.

Read More

Surging Aging Population Boosts Medical Exoskeleton Industry

The medical exoskeleton market was USD 485.8 million in 2023, which will increase to USD 6,336.8 million, powering at a 44.8% CAGR, by 2030.

This growth is because of the surging number of individuals with physical disabilities, the rising number of orthopedic surgeries, and the mounting elderly populace. For example, as per the WHO, 1 in 6 individuals globally, or around 1.3 billion individuals, experience substantial disability.

Furthermore, the mounting number of serious injuries, strokes, and road accidents is assisting the industry expansion. Around 1.3 million individuals die every year due to road traffic accidents, according to the WHO. Therefore, the rising acceptance of medical exoskeletons to heal injuries is further boosting this expansion.

In 2023, the hardware category, based on component, led the industry, with a 60% share, and it will propel at a 45.0% CAGR, during this decade. This can be because exoskeletons are produced with different pieces of hardware like sensors, actuators, control systems, and powered systems.

The powered category is the larger type, primarily owing to the new developments in them. For example, with investment from the National Institutes of Health, Stanford University has created an exoskeleton that rapidly adapts to users’ motions while they walk naturally.

Moreover, the passive category is a significant contributor to the industry. Passive exoskeletons are mainly accepted in low-income and developing nations, particularly by those who can’t buy the powered ones.

North America led the industry in 2023, with a 55% share, and it will further advance at a significant rate, in the years to come. This will be because of the mounting aging populace, rising government support for exoskeletons, and the high occurrence of neurological illnesses.

APAC is the fastest-growing region. This can be primarily ascribed to the increasing funding in healthcare, the growing patient pool requiring mobility support and rehabilitation, and the latest product approvals.

With the surge in the elderly populace across the globe, the medical exoskeleton industry will continue to progress in the years to come.

Read More

Wireless Technologies was the Leader of the Medical Device Connectivity Market

The medical device connectivity market was USD 2,531.7 million in 2023, which will touch USD 11,879.4 million by 2030, powering at a rate of 24.8% by the end of this decade. This has a lot to do with the growth in the telehealth and remote patient monitoring segments.

To learn more about this report: https://bit.ly/3TGMLXJ

Likewise, the growing preference for home healthcare will present substantial potential predictions for companies in the medical device connection sector.

The solutions category held a larger revenue share, of 70%, in 2023. This is credited to the increasing adoption of HIE and EHR devices, the surging need for integrated healthcare systems, the expanding regulatory standards and healthcare reforms, and the migration of point-of-care diagnostics from hospitals to home care settings.

The wireless technologies category led the industry with19 a share of 45%, in 2023. This is for the reason that these technologies offer superior patient care, and health of the patient can be incessantly monitored by medics and caregivers, who can also get instantaneous updates, letting for faster treatment.

Moreover, these aid in shorter stay times in healthcare amenities and remote patient monitoring to guarantee safety and patient care.

North America led the industry with a share of 50%, in 2023. This is attributable to the rising incidence of chronic ailments, the surging acceptance of healthcare IT solutions, the expansion of pioneering technologies, the growing public consciousness of health problems, and the mounting healthcare spending in the region.

It is because of the growing prevalence for home healthcare all over the world, the demand for medical device connectivity is on the rise, This trend will continue in the years to come as well.

Read More

Patient Registry Software Market To Grow Faster in the Integrated Category

The value of the patient registry software market was USD 2,091 million in 2023, which will reach USD 5,638.3 million by 2030, powering at a rate of 15.3% by the end of this decade.

To learn more about this report: https://bit.ly/41l3IZb

The requirement for integrated registries is boomed by the increasing incidence of chronic ailments, for example cancer, diabetes, and CVD, and the growing acceptance of EHR.

The disease registry generated the highest revenue, of USD 1.1 billion, in 2023. Patients with certain diseases are registered in these registries.

The ascendence of this category is because of the aging of the populace, increase in the chronic and novel disease incidence, advance in the understanding of the significance of registries in health management, and extensive acceptance of EHRs.

In the years to come, the integrated category will grow faster in the patient registry software market. An integrated system is a software collection used to monitoring the locations affected by an ailment and evaluate the efficiency of clinical involvement. It similarly helps learn more about illness prevalence and the effectiveness of treatment options.

Numerous modules of integrated software offer various functionalities, which are not common in standalone applications.

In hospitals, where numerous registers must be kept in several departments, and cross-sharing of this data through departments is important, integrated software is used more often.

A distinct group of people's clinical health results are improved by improved care coordination and patient participation, supported by appropriate monetary and care models. 

This procedure is called population health management.  Collection of data is the preliminary step in every population health management strategy. A populace is distinct by data including environmental, cultural, and community statistics, and health info from medical records.

It is because of the increasing prevalence of chronic diseases all over the world, the demand for patient registry software is on the rise. This trend will continue in the years to come as well.

Read More

Surgical Planning Software Market is Driven by Growing Occurrence of Car Accidents

The surgical planning software market was USD 117.8 million in 2023, which will touch USD 183.7 million, powering at a 6.6% compound annual growth rate, by 2030.

These tools assist doctors in producing precise digital information so that they can choose the suitable surgery. This assists in offering correct treatment to patients as well as saving cost and time in the complete procedure.

In this regard, a surging count of surgeries, a booming elderly populace, and various technological developments in healthcare IT, are the major factors assisting the growth of this industry.

Moreover, the growing incidence of car accidents as well as sports injuries in the old and young populaces is also likely to assist the progression of this industry.

North America was the largest contributor to the industry in 2023, with USD 0.06 billion. This can be mainly because of the rapid acceptance of novel, developed healthcare technologies in this region. 

Furthermore, enormous funds are given by different government organizations for medical R&D, particularly in important areas like oncology, neurology, and cardiology.

APAC will advance at the fastest rate during this decade, of 7.0%, because of the mounting elderly populace and constant progression in surgical technologies.

With the rise in the prevalence of car accidents, the surgical planning software industry will continue to progress in the coming years.

Read More

Bioanalytical Testing Services Market was Led by the Small Molecule Category

The value of the bioanalytical testing services market is USD 3,456.6 million in 2023, and it will power at a rate of 15.9% by the end of this decade, to touch USD 9,652.6 million by 2030.

This is credited to the well-known life sciences industry using bioanalytical testing, the existence of main service providers, the increased count of continuing clinical trials, high R&D spending, and the development of biosimilar and generic markets.

The small molecule category held the largest share of 50%, in 2023, and will maintain its dominance in the years to come. This is for the reason that small molecules are traditional pharma, and naturally they have a low molecular weight of less than 900 Daltons and adjust a biological procedure.

Furthermore, numerous outsourcing companies are offering studies on numerous small molecules for example pharmacodynamic studies, pharmacokinetic studies, and assays of biomarkers.

Based on test type, the bioavailability category had the largest share, of 40%, in 2023, and it will also be like this in the years to come as well. This is because of the high requirement for these services in generic molecule expansion.

North America bioanalytical testing services market was the leader of the pack of about 45%, in 2023, and the industry will experience a robust rate in the years to come. 

This is because of the presence of numerous patients with chronic ailments, the increase in the acceptance of large molecule therapeutics and peptides, substantial growth in the pharma and biotech industries, and the existence of key service providers for the regional industry.

It is because of the growth in the count of ongoing clinical trials all over the world, the demand for bioanalytical testing services will continue to grow in the years to come as well.

Read More

Propelled by Growing Awareness regarding Importance Of Immunization, Vaccine Adjuvants Industry To Reach $1,375.9 Million by 2030

The value of the vaccine adjuvants market stood at USD 877.5 million in 2023, and this number is projected to reach USD 1,375.9 million by 2030, advancing at a CAGR of 6.7% during 2023–2030. This development of the market can be credited to the increasing occurrence of infectious diseases and the intensifying usage of vaccine adjuvants, as a result.

Government officials and biotechnology and pharmaceutical companies have understood the worth of communicable disease research in the rouse of the novel coronavirus epidemic. For instance, through the Health Resources and Services Administration, the U.S. Department of Health and Human Services (HHS) declared a new USD 350 million fund in November 2022 for HRSA-supported health centers, to raise COVID-19 vaccination rates in their societies, with a special focus on marginalized people.

There has been a substantial rise in study initiatives in healthcare, credited to the extreme growth in the load of numerous infectious and noncontagious illnesses. For instance, the rising cases of cancer because of poor lifestyles, mainly because of tobacco consumption, poor diet, and smoking, have led to strong research in order to make better and more effective solutions for its treatment, prevention, and diagnosis.

In 2023, on the basis of product segment, the particulate category dominated the industry share of 35%. The obtainability of an extensive range of items and their growing efficiency against the target illnesses can be ascribed to this dominating share. Adjuvants made of alum, cytokines, and virosomes are comprised in the category of particulates.

In 2023, according to regional analysis, North America accounted for 45% of the global market. The presence of the largest players, well-established health infrastructure, technological advancement, and good healthcare reimbursement policies in this region are considered to give rise to such dominance. The main factors contributing to this are the wide use of Innovative Technologies in healthcare, as well as the growing demand for higher quality health services.

Hence, the robust government backing for illness prevention and treatment R&D and the initiation of immunization programs boost the industry for vaccine adjuvants.

Read More

North America Dominated the Virtual Clinical Trials Industry

The size of the virtual clinical trials industry will power at a compound annual growth rate of 5.9% during 2022-2030, to touch a value of USD 12,987.4 million by 2030.

To learn more about this report: https://bit.ly/44yjyA0

This is due to rising rate of digitization in the healthcare industry, surging clinical research activities, and the increasing demand for new vaccines and treatments and technologies that allow clinical trials to be conducted online.

The market is going through clinical trial platforms and technological developments in patient recruitment which have made it possible to analyse trial data effectively.

In a fully decentralised or virtual approach, patient recruitment, intervention delivery, and outcome data collection can all be completed without the patients' actual physical presence.

Virtual clinical trials are a revolutionary method that allows participants to take part in the study from the comfort of their own homes without travelling to the study site. Additionally, this aids in maintaining effective control over the gathering of participant data for clinical trials.

Clinical trials have become more patient-centric due to decentralised technologies, which have also revolutionised product development. As a result, market participants are working on a variety of strategic initiatives to provide the finest services and to reduce trial costs. 

The interventional category maintained the greatest share, around 50% due to the increased number of research and development efforts focused on innovative medicines and digitization at the laboratory level.

Experimental research also known as interventional studies, enables the medical community to determine the cause-and-effect between an intervention or treatment. When doing epidemiological research on preventative or therapeutic products, such studies provide trustworthy evidence.

Decentralised platforms, tools, and solutions are anticipated to gain more focus as a result of strong government support and severe clinical trial laws in the United States. Additionally, governments in a number of poor nations are launching measures to increase the quantity of clinical studies.

Due to the presence of many significant market players, North America held a 40% share of the global virtual clinical trials market. The market is also fuelled by expanding R&D spending, the use of new technologies in clinical research, and government funding for pharmaceutical research. 

For instance, from 19.1% in 2021 to 20.7%, the rate of new research project grant success grew by 1.6%. Additionally, the NIH spent over USD 43 billion on research to lessen the burden of disease.

Furthermore, the U.S. accounts for the biggest share—more than 31%—of all clinical studies reported globally. Additionally, this nation accounts for more than 32% of all patient recruiting for similar research worldwide.

Traditional clinical trial methods are becoming obsolete due to the rising number of registrations; hence the virtual method is expected to be used most in the upcoming years and this will lead to market growth.

Read More

Amniotic Products Industry Is Led by North America

The amniotic products market was USD 810.4 million in 2022, and it will advance at an 8.7% compound annual growth rate, to touch USD 1,451.2 million, by 2030.

To learn more about this report: https://bit.ly/3P8MUQF

The growth of the industry is ascribed to the continuing research to enlarge the application area, utilization of these products for the treatment of eye and skin illnesses, and increasing prevalence of traumatic wounds and injuries because of burns, as well as the rising consciousness about the usage of amniotic products for their treatment.

In 2022, the membranes category, based on type, accounted for the largest share of the industry, of 80%. This is credited to the superior effectiveness of membranes over suspensions. Moreover, the category will advance at an exponential rate because of the increasing utilization of such membranes for various ophthalmic problems.

In 2022, the North American amniotic products industry was the largest contributor, with a 60% share. This is primarily attributed to the existence of well-established healthcare facilities and key industry players. Moreover, the surging focus being given to alternative technologies will further boost the growth of the regional industry.

APAC is likely to witness the fastest growth, with a 9% compound annual growth rate, in the years to come. This can be attributed to the rising disposable income and the economic growth across the nations of the region.

Moreover, several global companies are making notable findings in this area. Large unmet requirements and rising infrastructure of healthcare, mainly in India and Japan, will further boost the growth of the regional industry.

It is because of the increasing prevalence of traumatic wounds and injuries because of burns and the surging treatment for skin and eye disorders, the amniotic products industry will continue to advance in the years to come.

Read More

Pharmaceutical Sterility Testing Industry IS Dominated by North America

The pharmaceutical sterility testing market will reach USD 2,953.9 million by 2030, growing at a rate of 11.2% during 2023–2030. This is because of the development of biotech and pharma firms, an increase in their R&D activities, an increase in the incidence of diseases, and substantial government spending on the healthcare industry.

To learn more about this report: https://bit.ly/3KQmVer

The increasing occurrence of diseases in the pest has brought about an increase in R&D activities for the manufacturing of effective and safe therapeutics. Regarding this, the continuing studies on the preventing severe viral infections, such as the novel coronavirus, and those centered on the expansion of effective and safe vaccines have a positive impact on the industry.

The occurrence of hematological malignancies is increasing. As per the Leukemia & Lymphoma Society, every 3 minutes, a person is identified with leukemia, myeloma, or lymphoma in the U.S. Biopharma, for example gene, and immune cell therapies are quickly being accepted as a substitute treatment for hematological cancers. This is due to the fact that such therapeutics have high effectiveness and efficacy against these kinds of diseases.

North America pharmaceutical sterility testing market had a major share of 40%, in 2022. This is credited to the presence of leading pharma and biopharma players, increasing R&D activities in the biotech and pharma industry, increasing number of product introductions, high occurrence of chronic ailments, and supportive policies of the government for the setup of R&D facilities. 

Furthermore, Europe follows North America in terms of revenue share. This is attributable to the formation of universal public healthcare systems in numerous nations in the region, which has considerably increased the requirement for healthcare products. The employment of stringent regulatory policies with regards to the safety of drugs is another key factor contributing to the growth of the industry.

The increasing acceptance of digital platforms has a positive impact on the demand for pharmaceutical sterility testing, and this will be the trend in the years to come as well.

Read More

Single Use Bioreactor Market Was Led by North America

The single-use bioreactors market will grow at a 18.8% CAGR in the years to come, and will reach to a value of USD 13,595.9 million by 2030. The growth of the industry is powered by the increasing prevalence of infectious and chronic diseases.

To learn more about this report: https://bit.ly/3NZBbmV

There has been a significant increase in the number of infectious diseases worldwide. The COVID-19 pandemic has led to the rapid adoption of advanced technologies by life sciences and biopharmaceutical firms to produce vaccines quickly and on a large scale. 

This has brought about a growing demand for single-use systems, which are flexible and modular, allowing for local manufacturing facilities in emerging nations that lack investments. These systems are mainly utilized in the production of viral vaccines.

To better understand the COVID-19 virus's behavior in humans, some manufacturers are using bioreactors to cultivate suitable host cells. Additionally, several companies have entered in collaborations to enhance their market positions. 

North America dominates the single-use bioreactors market due to factors like the high prevalence of chronic diseases, presence of top players, advanced healthcare facilities, technological advancements and strong research and development initiatives. 

Within North America, the U.S. plays a significant role, driven by the adoption of innovative technologies, public awareness regarding disease prevention, government support, and advanced healthcare infrastructure.

The vaccines category had the largest revenue share in 2022 due to the increase in infectious diseases. The demand for mass production of vaccines for prevention and treatment purposes has increased. The COVID-19 pandemic further accelerated vaccine manufacturing, leading to the adoption of single-use bioreactors. 

Lab-scale production is leading the industry. This is due to the fact that the biopharma industry requires the frequent use of bioreactors for various preclinical and clinical research purposes. 

Moreover, the increasing acceptance and progressions in single-use technologies will all boost the expansion of the industry, a great deal in the future.

It is because of the increasing research and development activities in the medical industry, that the demand for single-use bioreactors will continue to rise in the years to come.

Read More

North America is Dominating Respiratory Care Device Industry

In 2021, the respiratory care device market was worth around USD 19,257.2 million, and it is predicted to advance at a 7.9% CAGR from 2021 to 2030, hitting USD 38,085.6 million in 2030. The major reasons behind the growth of this market are the surging incidence of preterm births and the growing geriatric population.

To learn more about this report: https://bit.ly/3O3ZGQh

Furthermore, because of the pandemic, there was a rapid growth in the demand for medical equipment globally, including ventilators and other vital monitors. At the peak of the covid out bust such devices are required to be tailored to treat seriously ill patients. For example, for patients who need ventilation for a longer period, became important to deliver portable ventilators and compact anesthesia devices.

Rapid Urbanization has impacted the environment and lifestyle. WHO says, in the 21st century, cities are home to around 55% of the global population and are expected to increase by 68% by 2050.

According to WHO report air pollution sources over 4 million premature deaths globally every year. The emission of carbon due to the burning of fuels in domestic appliances, motor vehicles, and industrial equipment causes cancers, respiratory diseases, and cardiovascular conditions. 

Globally, therapeutic devices held the largest revenue share of around 60% in 2021. The surging frequency of respiratory illnesses and the growing number of operations boost the demand for therapeutic devices which in turn, contributes to the growth of this category in coming years.

In South Asia and Africa, the occurrence of preterm births is around 60%, as per WHO, around 15 million preterm babies are born every year, also in other countries the rate of preterm births is around 5% to 18%. As per the report by CDC, in the U.S., in 2020, preterm births affected around 1 of every 10 infants born.

Tobacco consumers are more prone to suffer from, lung diseases, cardiovascular diseases, and cancer. According to WHO, Smoking causes around 42% of COPD, 10% of CVD, and 71% of lung cancer cases every year. Furthermore, 80% of smokers globally live in low-income countries, which in turn will cause more life-threatening respiratory illnesses.  

Hence, the major reasons behind the growth of this market are the surging incidence of preterm births and the growing geriatric population.

Read More